Back to top

Jefferies Keeps Their Buy Rating on Teva Pharmaceutical (TEVA)

In a report released today, Dennis Ding from Jefferies maintained a Buy rating on Teva Pharmaceutical, with a price target of $40.00. According to ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Teva Pharmaceutical Industries Ltd. (TEVA)